-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
PDS Biotechnology Corp quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2014 to Q2 2024.
- PDS Biotechnology Corp Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was -$869K, a 38.2% increase year-over-year.
- PDS Biotechnology Corp annual Income Tax Expense (Benefit) for 2023 was -$1.41M, a 17.3% decline from 2022.
- PDS Biotechnology Corp annual Income Tax Expense (Benefit) for 2022 was -$1.2M, a 73.5% increase from 2021.
- PDS Biotechnology Corp annual Income Tax Expense (Benefit) for 2021 was -$4.52M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)